Alessandro Larcher
Overview
Explore the profile of Alessandro Larcher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
288
Citations
2663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amparore D, Piramide F, Verri P, Checcucci E, Piana A, Basile G, et al.
Eur Urol Open Sci
. 2025 Mar;
74:11-20.
PMID: 40066189
Background And Objective: The aim of our study was to compare assessment of PADUA and RENAL nephrometry scores and risk/complexity categories via two-dimensional (2D) imaging and three-dimensional virtual models (3DVM)...
2.
Clinical predictors of bladder outlet obstruction in men consulting for routine urological screening
Raffo M, Capogrosso P, Pozzi E, Belladelli F, Corsini C, Bertini A, et al.
Int Urol Nephrol
. 2025 Mar;
PMID: 40045050
Purpose: Lower urinary tract symptoms (LUTS) associated with bladder outlet obstruction (BOO) are prevalent among men, notwithstanding being self-underreported. We aimed to assess the predictors for BOO during first visit....
3.
Longoni M, Rosiello G, Scilipoti P, Belladelli F, Trevisani F, Re C, et al.
Urol Oncol
. 2025 Jan;
PMID: 39880768
Introduction: The American Urology Association (AUA) recently introduced in their guidelines a subtype-agnostic, 4-tiered risk classification score to assess oncologic outcomes after surgery in patients with localized renal cell carcinoma...
4.
Wurnschimmel C, Paciotti M, Wenzel M, Bravi C, De Groote R, Delloglio P, et al.
BJU Int
. 2025 Jan;
135(3):366-368.
PMID: 39807761
No abstract available.
5.
Larcher A, Gelardi F, Montorsi F, Capitanio U, Chiti A
Lancet Oncol
. 2025 Jan;
26(1):e1.
PMID: 39756448
No abstract available.
6.
Scuderi S, Scilipoti P, Nocera L, Longoni M, Quarta L, Zaurito P, et al.
Urol Oncol
. 2024 Dec;
43(4):271.e1-271.e8.
PMID: 39690076
Purpose: The utility of a pelvic drain (PD) after robot-assisted radical prostatectomy (RARP) has been recently questioned. We investigated the impact of discontinuing PD placement after RARP on complications, pain,...
7.
Scilipoti P, Rosiello G, Belladelli F, Pellegrino F, Trevisani F, Bettiga A, et al.
Urol Oncol
. 2024 Nov;
PMID: 39616023
Background: The impact of warm ischemia time (WIT) on renal function after partial nephrectomy (PN) remains debated. This study investigates the effect of WIT on the relationship between preoperative comorbidities...
8.
Trevisani F, Floris M, Trepiccione F, Rosiello G, Capasso G, Pani A, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518690
: Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) are significant risks for kidney cancer (KC) patients undergoing partial (PN) or radical nephrectomy (RN) and for living kidney donors...
9.
Bravi C, Delloglio P, Pecoraro A, Khene Z, Campi R, Diana P, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39408076
In patients treated with partial nephrectomy, prior evidence showed that peri-operative outcomes, such as complications and ischemia time, improved as a function of the surgical experience of the surgeon, but...
10.
Scilipoti P, Rosiello G, Belladelli F, Gambirasio M, Trevisani F, Bettiga A, et al.
Eur Urol Open Sci
. 2024 Sep;
69:73-79.
PMID: 39329070
Background And Objective: Metabolic syndrome (MetS) is a clinical condition associated with higher rates of overall and cardiovascular mortality. There is scarce evidence regarding the impact of MetS on surgical...